Mixture experimental design applied to solubility predictions

被引:8
作者
Vojnovic, D
Chicco, D
机构
[1] Dept. of Pharmaceutical Sciences, University of Trieste
关键词
D O I
10.3109/03639049709150764
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The solubility of theophylline (as a model drug) was studied in four-component systems, using an a priori experimental strategy. Ethanol, polyethylenglycol, propylenglycol, and water were chosen as cosolvents. A reduced cubic model was postulated to describe the solubility as a function of mixture composition. A priori criteria in combination with an exchange algorithm were used to select, from a set of 31 candidate points, the optimal design with the least number of experiments. A weighting was assigned to each of the 31 experiments, on the basis of the cost, in order to obtain a design that would be optimal also from an economic point of view. Such a methodology made it possible to obtain, with the minimum number of experiments and with a low cost, a model which was validated and found suitable for accurate prediction of solubility.
引用
收藏
页码:639 / 645
页数:7
相关论文
共 16 条
[1]   EXTREME VERTEXES DESIGN IN FORMULATION DEVELOPMENT - SOLUBILITY OF BUTOCONAZOLE NITRATE IN A MULTICOMPONENT SYSTEM [J].
ANIK, ST ;
SUKUMAR, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (08) :897-900
[2]   STATISTICAL TECHNIQUES APPLIED TO SOLUBILITY PREDICTIONS AND PHARMACEUTICAL FORMULATIONS - AN APPROACH TO PROBLEM-SOLVING USING MIXTURE RESPONSE-SURFACE METHODOLOGY [J].
BELLOTO, RJ ;
DEAN, AM ;
MOUSTAFA, MA ;
MOLOKHIA, AM ;
GOUDA, MW ;
SOKOLOSKI, TD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 23 (02) :195-207
[3]  
CHU JS, 1991, PHARMACEUT RES, V11, P1401
[4]   SOME COMMENTS ON DESIGNS FOR COXS MIXTURE POLYNOMIAL [J].
CORNELL, JA .
TECHNOMETRICS, 1975, 17 (01) :25-35
[5]  
Cornell JA, 2002, EXPT MIXTURES DESIGN
[6]   FORMULATION OPTIMIZATION OF SUSTAINED-RELEASE TABLET OF CHLORPHENIRAMINE MALEATE BY MEANS OF EXTREME VERTICES DESIGN AND SIMULTANEOUS-OPTIMIZATION TECHNIQUE [J].
HIRATA, M ;
TAKAYAMA, K ;
NAGAI, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (03) :741-746
[7]  
JOHNSON AD, 1990, PHARM RES, V10, P1092
[8]   MIXTURE DESIGN OF THEOPHYLLINE RETARD FORMULATION [J].
KRISTL, A ;
VOJNOVIC, D ;
KARBA, R ;
MRHAR, A ;
RUBESSA, F ;
ZUPANI, B .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 100 (1-3) :33-40
[9]   NONCLASSICAL EXPERIMENTAL-DESIGNS IN PHARMACEUTICAL FORMULATION [J].
LEWIS, GA ;
CHARIOT, M .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (12) :1551-1570
[10]  
MATHIEU D, 1995, NEMROD NEW EFFECIENT